Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis
检查雌二醇对围绝经期快感缺失和精神病患者奖励的神经和分子反应的影响
基本信息
- 批准号:10348271
- 负责人:
- 金额:$ 77.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnhedoniaBehaviorBiologicalBiological MarkersBrainClinical TrialsCorpus striatum structureDataDepressive SyndromesDistressDopamineDopamine AntagonistsDouble-Blind MethodEndocrineEnsureEstradiolEstrogen TherapyEtiologyFunctional Magnetic Resonance ImagingFunctional disorderFutureGrantImpairmentIncidenceMagnetic Resonance ImagingMeasuresMenopauseMental DepressionMental disordersModelingMolecularMood DisordersMoodsMorbidity - disease rateParticipantPathogenesisPerimenopausePhasePlacebo ControlPlacebosPlayPositron-Emission TomographyPredispositionPsychosesRacloprideRandomizedResearchRewardsRiskRoleSamplingSeveritiesStratificationSymptomsTimeWithdrawalWomanWorkdesigndimensional analysisdopamine D3 receptordopamine systemexperimental groupfunctional disabilityimprovedmesolimbic systemmolecular imagingmortalityneuromechanismneurotransmissionnovelplacebo grouppre-clinicalrecruitrelating to nervous systemreproductiveresponsereward anticipationreward circuitryreward processingtargeted imagingtreatment response
项目摘要
Project Summary
Affective disorders are highly prevalent in women and associated with significant morbidity and
mortality, particularly during times of reproductive transition, including the transition to
menopause. Unraveling the pathophysiology of affective disorders is challenging because
depressive syndromes are heterogeneous and have diverse etiologies. Thus, studies aimed at
identifying biomarkers to improve the prediction of susceptibility and illness course as well as
treatment response in affective disorders have yielded inconsistent results. We propose to
address this challenge by studying symptoms that initially present during the menopause
transition and thus have a common endocrine trigger. We believe that studying a relatively
homogeneous group of participants with similar biological mechanisms of symptom onset will
increase the likelihood of elucidating the pathogenesis of perimenopausal-onset symptoms. This
proposal will use simultaneous positron emission tomography and functional magnetic
resonance imaging (PET-MR) to examine relations between reward-related striatal activation
measured by fMRI and tonic and phasic striatal DA activity measured by [11C]raclopride PET in
a transdiagnostic sample of women with varying severities of perimenopausal-onset (PO)
anhedonia and psychosis. Specific Aim 1 will examine associations between PO anhedonia and
psychosis symptom severity and reward-related striatal activation measured by fMRI and tonic
and phasic striatal DA activity measured by [11C]raclopride PET. Specific Aim 2 will examine
relations between anhedonia reductions due to estradiol administration, relative to placebo, and
changes in PET-MR metrics related to reward processing. Specific Aim 3 will examine relations
between PO psychosis reductions due to estradiol, relative to placebo, and changes in PET-MR
metrics related to reward processing. Our central hypotheses are that the mesolimbic dopamine
system is impaired during reward processing in PO anhedonia and psychosis, that the effects of
estradiol administration will be associated with normalization of neural responses to rewards
measured by fMRI and striatal dopamine functioning measured by PET, and that the degree of
change in striatal functioning measured by fMRI and PET will be associated with the magnitude
of change in PO anhedonia and psychosis symptom severity. The results of this project will
increase our understanding of anhedonia and psychosis vulnerability during the menopause
transition and have the potential to deliver validated molecular imaging targets to use in future
mechanistic clinical trials of novel treatments for perimenopausal-onset psychiatric disorders.
项目概要
情感障碍在女性中非常普遍,并且与显着的发病率和相关性相关。
死亡率,特别是在生殖过渡时期,包括向
绝经。阐明情感障碍的病理生理学具有挑战性,因为
抑郁综合征具有异质性并且有不同的病因。因此,研究旨在
识别生物标志物以改善易感性和病程的预测以及
情感障碍的治疗反应产生了不一致的结果。我们建议
通过研究更年期最初出现的症状来应对这一挑战
转变,因此具有共同的内分泌触发因素。我们认为,研究相对
具有相似症状发生生物学机制的同质参与者群体将
增加阐明围绝经期症状发病机制的可能性。这
该提案将使用同时正电子发射断层扫描和功能磁
磁共振成像(PET-MR)检查奖赏相关纹状体激活之间的关系
通过 fMRI 测量,强直和阶段性纹状体 DA 活性通过 [11C]雷氯必利 PET 测量
具有不同严重程度的围绝经期发作 (PO) 的女性的跨诊断样本
快感缺失和精神病。具体目标 1 将检查 PO 快感缺乏与
通过功能磁共振成像和强直测量精神病症状的严重程度和奖励相关的纹状体激活
和通过[11C]雷氯必利 PET 测量的阶段性纹状体 DA 活性。具体目标 2 将审查
相对于安慰剂,雌二醇给药引起的快感缺乏减少之间的关系,以及
与奖励处理相关的 PET-MR 指标发生变化。具体目标 3 将检查关系
相对于安慰剂,雌二醇导致 PO 精神病减少与 PET-MR 变化之间的关系
与奖励处理相关的指标。我们的中心假设是中脑边缘多巴胺
PO 快感缺失和精神病的奖励处理过程中系统受到损害,
雌二醇的施用将与奖励的神经反应正常化相关
通过 fMRI 测量和通过 PET 测量纹状体多巴胺功能,并且
通过 fMRI 和 PET 测量的纹状体功能的变化将与幅度相关
PO 快感缺失和精神病症状严重程度的变化。该项目的成果将
增加我们对更年期快感缺失和精神病脆弱性的了解
转变并有潜力提供经过验证的分子成像目标以供将来使用
围绝经期精神疾病新疗法的机制临床试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GABRIEL S DICHTER其他文献
GABRIEL S DICHTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GABRIEL S DICHTER', 18)}}的其他基金
Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis
检查雌二醇对围绝经期快感缺失和精神病患者奖励的神经和分子反应的影响
- 批准号:
10544325 - 财政年份:2022
- 资助金额:
$ 77.11万 - 项目类别:
Clinical Translational Research Center for Neurodevelopmental Disorders
神经发育障碍临床转化研究中心
- 批准号:
10455486 - 财政年份:2020
- 资助金额:
$ 77.11万 - 项目类别:
Clinical Translational Research Center for Neurodevelopmental Disorders
神经发育障碍临床转化研究中心
- 批准号:
10673835 - 财政年份:2020
- 资助金额:
$ 77.11万 - 项目类别:
Clinical Translational Research Center for Neurodevelopmental Disorders
神经发育障碍临床转化研究中心
- 批准号:
10621066 - 财政年份:2020
- 资助金额:
$ 77.11万 - 项目类别:
Development of A Novel Transdiagnostic Intervention for Anhedonia
开发一种针对快感缺失的新型跨诊断干预措施
- 批准号:
10224009 - 财政年份:2017
- 资助金额:
$ 77.11万 - 项目类别:
Neural Circuits That Regulate Social Motivation in Autism
调节自闭症社交动机的神经回路
- 批准号:
9296174 - 财政年份:2017
- 资助金额:
$ 77.11万 - 项目类别:
Development of A Novel Transdiagnostic Intervention for Anhedonia
开发一种针对快感缺失的新型跨诊断干预措施
- 批准号:
9456980 - 财政年份:2017
- 资助金额:
$ 77.11万 - 项目类别:
Development of A Novel Transdiagnostic Intervention for Anhedonia
开发一种针对快感缺失的新型跨诊断干预措施
- 批准号:
9795076 - 财政年份:2017
- 资助金额:
$ 77.11万 - 项目类别:
A Simultaneous PET/MR Study of Striatal Dopamine Binding in Autism
自闭症纹状体多巴胺结合的同时 PET/MR 研究
- 批准号:
9245385 - 财政年份:2016
- 资助金额:
$ 77.11万 - 项目类别:
Imaging Genetic Predictors of Psychotherapy Outcomes in Unipolar Depression
单相抑郁症心理治疗结果的影像遗传预测因子
- 批准号:
8456070 - 财政年份:2012
- 资助金额:
$ 77.11万 - 项目类别:
相似海外基金
Childhood trauma, hippocampal function, and anhedonia among those at heightened risk for psychosis
精神病高危人群中的童年创伤、海马功能和快感缺失
- 批准号:
10825287 - 财政年份:2024
- 资助金额:
$ 77.11万 - 项目类别:
DNAメチル化障害とその量的形質遺伝子座を用いたanhedonia/dysphoria問題への接近
利用 DNA 甲基化障碍及其数量性状基因座解决快感缺乏/烦躁不安问题
- 批准号:
24K02698 - 财政年份:2024
- 资助金额:
$ 77.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Testing a Memory-Based Hypothesis for Anhedonia
测试基于记忆的快感缺失假设
- 批准号:
10598974 - 财政年份:2023
- 资助金额:
$ 77.11万 - 项目类别:
Reward Responsiveness as a Prevention Target in Youth At Risk for Anhedonia
将奖励反应作为快感缺失风险青少年的预防目标
- 批准号:
10722481 - 财政年份:2023
- 资助金额:
$ 77.11万 - 项目类别:
Determining the role of social reward learning in social anhedonia in first-episode psychosis using motivational interviewing as a probe in a perturbation-based neuroimaging approach
使用动机访谈作为基于扰动的神经影像学方法的探索,确定社交奖励学习在首发精神病社交快感缺乏中的作用
- 批准号:
10594181 - 财政年份:2023
- 资助金额:
$ 77.11万 - 项目类别:
Mapping links between real-world diversity, positive emotion, and neural dynamics in anhedonia
映射现实世界多样性、积极情绪和快感缺失的神经动力学之间的联系
- 批准号:
10716446 - 财政年份:2023
- 资助金额:
$ 77.11万 - 项目类别:
Neural Circuit-Specific Mechanisms of Ketamine's Effect on Anhedonia and Anxiety in Depression Using Ultra-High Field 7-Tesla MRI
使用超高场 7 特斯拉 MRI 研究氯胺酮对抑郁症快感缺乏和焦虑影响的神经回路特异性机制
- 批准号:
10713827 - 财政年份:2023
- 资助金额:
$ 77.11万 - 项目类别:
Neuroinflammation as a Mechanism Linking Early Life Stress, Altered Functional Connectivity, and Anhedonia in Major Depression
神经炎症是一种与早期生活压力、功能连接改变和重度抑郁症快感缺失相关的机制
- 批准号:
10606174 - 财政年份:2023
- 资助金额:
$ 77.11万 - 项目类别:
Neurophysiological mechanisms of anhedonia and cognitive control deficits in trauma-exposed people completing vibroacoustically augmented breath focused mindfulness
创伤暴露人群完成振动声学增强呼吸聚焦正念的快感缺失和认知控制缺陷的神经生理机制
- 批准号:
10752342 - 财政年份:2023
- 资助金额:
$ 77.11万 - 项目类别:
Mechanisms of Depression and Anhedonia in Adolescents: Linking Sleep Duration and Timing to Reward- and Stress-Related Brain Function
青少年抑郁和快感缺失的机制:将睡眠持续时间和时间与奖励和压力相关的大脑功能联系起来
- 批准号:
10364517 - 财政年份:2022
- 资助金额:
$ 77.11万 - 项目类别: